Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Rises By 5.1%

Aditxt, Inc. (NASDAQ:ADTX) saw a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 27,000 shares, a growth of 5.1% from the August 31st total of 25,700 shares. Approximately 0.5% of the company’s stock are short sold. Based on an average daily volume of 2,650,000 shares, the short-interest ratio is currently 0.0 days.

Aditxt Stock Down 25.6 %

ADTX opened at $0.16 on Monday. Aditxt has a fifty-two week low of $0.16 and a fifty-two week high of $24.00. The business has a 50-day moving average of $0.81 and a 200-day moving average of $1.73.

Shares of Aditxt are set to reverse split before the market opens on Wednesday, October 2nd. The 1-40 reverse split was announced on Friday, September 27th. The number of shares owned by shareholders will be adjusted after the closing bell on Tuesday, October 1st.

Aditxt (NASDAQ:ADTX) last announced its earnings results on Monday, August 19th. The company reported ($4.19) EPS for the quarter. The firm had revenue of $0.04 million during the quarter. Aditxt had a negative return on equity of 615.43% and a negative net margin of 5,016.31%.

Aditxt Company Profile

Aditxt, Inc, a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.